Junko Sawada

Junko Sawada

Auto-generated profile, based on publicly available information

Junko Sawada

Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2022 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
JSJunko Sawada
Junko Sawada
Nobuyoshi HiraokaNobuyoshi Hiraoka
Nobuyoshi Hiraoka
RQRongsu Qi
Rongsu Qi
LJLu Jiang
Lu Jiang
AFAshley E. Fournier-Goss
Ashley E. Fournier-Goss
MKMasanobu Komatsu
Masanobu Komatsu
High endothelial venules (HEV) are specialized post-capillary venules that recruit naïve lymphocytes to lymph nodes. HEVs are essential for the development of adaptive immunity. HEVs can also develop in tumors where they are thought to be important for recruiting naïve T cells and B cells into the tumors and locally enhancing antitumor immunity by supporting the formation of tertiary lymphoid structures. Herein, we used comparative transcriptome analysis of human breast cancer to investigate genes differentially expressed between tumor-associated HEVs and the rest of the tumor vasculature. Tumor vessels highly expressing HEV-upregulated genes, such as the homeobox gene MEOX2 and the tetraspanin gene TSPAN7, were associated with extensive infiltration of T and B cells and the occurrence of tertiary lymphoid structures, which is known to predict therapeutic responses to immune-checkpoint inhibitors. Moreover, high transcript counts of these genes in clinical tumor specimens were associated with a significant survival benefit in advanced breast cancer. The molecular signature of HEVs identified herein may be useful for guiding immunotherapies and provides a new direction for investigating tumor-associated HEVs and their clinical significance. See related Spotlight by Gallimore, p. 371.

2 September 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
JSJunko Sawada
Junko Sawada
YKYasuhiro Kikuchi
Yasuhiro Kikuchi
MDMaxwell Duah
Maxwell Duah
JHJose Luis Herrera
Jose Luis Herrera
FKFumiaki Kanamori
Fumiaki Kanamori
MKMasanobu Komatsu
Masanobu Komatsu
B cell-rich tertiary lymphoid structures (TLS) are associated with favorable prognosis and positive response to immunotherapy in cancer. Here we show that simultaneous activation of innate immune effectors, STING and lymphotoxin-β receptor (LTβR), results in CD8+ T cell-dependent tumor suppression while inducing high endothelial venule development and germinal center-like B cell responses in tumors to generate functional TLS in a T cell-dependent manner. In a neoadjuvant setting, activation of STING and LTβR by their agonists effectively immunized mice against tumor recurrence, leading to long-term survival. STING activation alone was insufficient for inducing B cell-containing TLS or eliciting long-term therapeutic effects. However, when combined with LTβR activation, it improved the fitness of TLS with B cell expansion and maturation to IgG-producing long-lived plasma cells and memory cells, increased CD4+ T cell recruitment and memory CD8+ T cell expansion, and shifted the TH2/TH17 balance, resulting in the potentiation of humoral and cellular immunity against tumors. These findings suggest a therapeutic approach of simultaneously activating STING and lymphotoxin pathways.

2 September 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
BLBongyong Lee
Bongyong Lee
ASAnupama Sahoo
Anupama Sahoo
JSJunko Sawada
Junko Sawada
JMJohn Marchica
John Marchica
SSSanjay Sahoo
Sanjay Sahoo
RPRanjan Perera
Ranjan Perera

4 April 2023
Verified
Other
Open access
JSJunko Sawada
Junko Sawada
Nobuyoshi HiraokaNobuyoshi Hiraoka
Nobuyoshi Hiraoka
RQRongsu Qi
Rongsu Qi
LJLu Jiang
Lu Jiang
AFAshley E. Fournier-Goss
Ashley E. Fournier-Goss
MKMasanobu Komatsu
Masanobu Komatsu
High endothelial venules (HEV) are specialized post-capillary venules that recruit naïve lymphocytes to lymph nodes. HEVs are essential for the development of adaptive immunity. HEVs can also develop in tumors where they are thought to be important for recruiting naïve T cells and B cells into the tumors and locally enhancing antitumor immunity by supporting the formation of tertiary lymphoid structures. Herein, we used comparative transcriptome analysis of human breast cancer to investigate genes differentially expressed between tumor-associated HEVs and the rest of the tumor vasculature. Tumor vessels highly expressing HEV-upregulated genes, such as the homeobox gene MEOX2 and the tetraspanin gene TSPAN7, were associated with extensive infiltration of T and B cells and the occurrence of tertiary lymphoid structures, which is known to predict therapeutic responses to immune-checkpoint inhibitors. Moreover, high transcript counts of these genes in clinical tumor specimens were associated with a significant survival benefit in advanced breast cancer. The molecular signature of HEVs identified herein may be useful for guiding immunotherapies and provides a new direction for investigating tumor-associated HEVs and their clinical significance.See related Spotlight by Gallimore, p. 371.

4 April 2023
Verified
Other
Open access
JSJunko Sawada
Junko Sawada
Nobuyoshi HiraokaNobuyoshi Hiraoka
Nobuyoshi Hiraoka
RQRongsu Qi
Rongsu Qi
LJLu Jiang
Lu Jiang
AFAshley E. Fournier-Goss
Ashley E. Fournier-Goss
MKMasanobu Komatsu
Masanobu Komatsu
Supplementary Figure from Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival

4 April 2023
Verified
Other
Open access
JSJunko Sawada
Junko Sawada
Nobuyoshi HiraokaNobuyoshi Hiraoka
Nobuyoshi Hiraoka
RQRongsu Qi
Rongsu Qi
LJLu Jiang
Lu Jiang
AFAshley E. Fournier-Goss
Ashley E. Fournier-Goss
MKMasanobu Komatsu
Masanobu Komatsu
Supplementary Figure from Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival